MIB Agents Awards $200,000 in Grants to Colorado-based Researchers Studying Pediatric Osteosarcoma

MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, recently presented $100,000 each to Michael Leibowitz, MD, PhD from the University of Colorado Cancer Center and Dr. Daniel Regan, DVM, PhD, DACVP from the Flint Animal Cancer Center at Colorado State University, totaling $200,000 in research funds to move rare bone cancer research forward. Christina Ip-Toma, MIB Agents’ Director of Scientific Programs, presented the award to Dr. Leibowitz on February 8 and Dr. Regan on February 9.

Verana Health Announces Release of Qdata Module for Non-Muscle Invasive Bladder Cancer RWE Analysis

Second Urology Qdata Module to Provide Real-World Evidence from more than 50,000 De-identified Patients in the American Urological Association’s (AUA) Quality Registry (AQUA)

Biopharma PEG Supplies Multi-arm PEG Derivatives Crosslinked Into Hydrogels

Huateng Pharma Supplies Tetrahydrocurcumin With Large Scale

About Huateng Pharma Huateng Pharma is a global provider in contract development and manufacturing for pharmaceutical intermediates. With our focus on operational excellence, and the integration of manufacturing operations with EHS, quality assurance, quality control, regulatory, supply chain management and project management, we can manufacture, scale-up and supply high-quality intermediates and APIs from our China facility. We have established a 5000 square meters R&D center and have our own manufacturing site covering 34,000 square meters. Contact us Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818

OncoDxRx Emerges from Stealth Mode with World-First PGA Technology

OncoDxRx's innovative technology, for the first time, brings two worlds together - from gene expression to drug efficacy.

BSI LIFE SCIENCES AND LEDGER RUN PARTNER TO STREAMLINE CLINICAL BUSINESS OPERATIONS

BSI Life Sciences specializes in state-of-the-art software for life sciences (CTMS, eTMF and more) and Ledger Run, Inc., an innovative technology company focused on optimizing clinical operations in the areas of site budgeting and payments, announced their partnership today. Through the partnership, BSI Life Sciences’ Clinical Trial Management software BSI CTMS™ and Ledger Run’s unique ClinRun™ platform will streamline and enhance clinical operation budgeting and payment processes with an intelligent approach and seamless integration.

BOC Sciences Established Large-Scale Fermentation Tanks of Different Volumes

Amerigo Scientific Releases Optimal ZediXclusive TG6-ab ELISA (IgA) Kits to Detect TG6-Autoantibodies in Human Sera

Amerigo Scientific released ZediXclusive TG6-ab ELISA Kits (IgA), optimized based on ZediXplore TG6-ELISA Kits (IgA) to support celiac disease-related studies.

‘Zero-Copy Integration’ Innovation Framework Published as National Standard of Canada

The new standard, called Zero-Copy Integration, provides a framework enabling companies to allow access to our information, rather than make copies of it, and allows controls be tied to the data itself over how and where it can be used.

DeciBio Consulting Ranks #1 in Innovation in the Vault Consulting 50 Best Firms to Work For

DeciBio Consulting, a strategy consulting firm dedicated to accelerating the adoption and impact of precision medicine technologies, received recognition as a top consulting firm to work for in North America. DeciBio received first place in Innovation, achieving its first #1 ranking since its founding one decade ago.

Quotient Sciences Expands Formulation Development Capabilities To Further Accelerate Drug Development Timelines

Company increases laboratory capacity to meet customer demand for fully integrated drug development capabilities

ZeOmega Ranked #1 Best in KLAS for Payer Care Management Solutions

Company recognized as top performer based on Jiva Population Healthcare Enterprise Management Platform’s configurability, reliability, and functionality

Lyniate Earns Best in KLAS® Distinction for Integration Engine Category with Overall Scores of 95.7 and 92

Medical futurist names three trends shaping the future of Pharma

GCMS Analysis Technology and Application

Gas Chromatography-Mass Spectrometry (GCMS) Analysis is a powerful analytical technique used to separate, quantify and identify compounds in a sample. It is a combination of two technologies, gas chromatography and mass spectrometry.

CAS and Torx Software collaborate to streamline and accelerate small molecule discovery and design

Flagship Biosciences and Genomenon Partner to Advance Precision Medicine Development

Genomenon’s genomic landscapes enhance Flagship’s biomarker services and companion diagnostic development solutions.

BOC Sciences Live Webinar on Sensitive Nucleic Acids: Applications and Chemical Synthesis

Professor Shiyue Fang from the Department of Chemistry, Michigan Technological University, accepted BOC Sciences' invitation to present his insightful ideas about sensitive nucleic acid applications and chemical synthesis.

BOC Sciences January 2023 Promo: An Economical (Bio)chemical Source for New Year Projects

As the new year approaches, BOC Sciences' January promotion is bang on time, as usual, to thank all regular customers for the year-round support and to welcome new partners to join.

Hexarad radiology technology cuts scan allocation time by 90%

The Hexarad auto-allocation tool automatically assigns scans to the most appropriate radiologist, cutting down admin burden and leading to faster and more accurate scan results.